Revance Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2014 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Revance Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2014 to Q3 2024.
  • Revance Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 31, 2024 was 105M shares, a 19.5% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 105M +17.1M +19.5% Oct 31, 2024 10-Q 2024-11-07
Q2 2024 105M +16.9M +19.2% Jul 31, 2024 10-Q 2024-08-08
Q1 2024 104M +20.4M +24.3% Apr 30, 2024 10-Q 2024-05-09
Q3 2023 87.8M +5.54M +6.73% Oct 31, 2023 10-Q 2023-11-08
Q2 2023 88M +14.8M +20.3% Jul 31, 2023 10-Q 2023-08-08
Q1 2023 84M +11.3M +15.5% Apr 28, 2023 10-Q 2023-05-09
Q3 2022 82.3M +10.5M +14.6% Oct 31, 2022 10-Q 2022-11-08
Q2 2022 73.1M +1.28M +1.78% Jul 29, 2022 10-Q 2022-08-09
Q1 2022 72.8M +1.24M +1.73% Apr 29, 2022 10-Q 2022-05-10
Q3 2021 71.8M +5.25M +7.88% Oct 28, 2021 10-Q 2021-11-09
Q2 2021 71.8M +5.9M +8.95% Jul 28, 2021 10-Q 2021-08-05
Q1 2021 71.5M +14.5M +25.4% Apr 27, 2021 10-Q 2021-05-10
Q4 2020 71.4M +14.5M +25.4% Feb 12, 2021 10-K 2021-02-25
Q3 2020 66.5M +21.4M +47.5% Oct 30, 2020 10-Q 2020-11-09
Q2 2020 65.9M +21.8M +49.5% Jul 24, 2020 10-Q 2020-08-06
Q1 2020 57.1M +13M +29.6% Apr 24, 2020 10-Q 2020-05-07
Q4 2019 56.9M Feb 13, 2020 10-K 2020-02-26
Q3 2019 45.1M +8.12M +22% Oct 24, 2019 10-Q 2019-11-04
Q2 2019 44.1M +7.16M +19.4% Jul 26, 2019 10-Q 2019-08-06
Q1 2019 44M +7.22M +19.6% May 3, 2019 10-Q 2019-05-09
Q3 2018 37M +6.05M +19.6% Oct 25, 2018 10-Q 2018-11-02
Q2 2018 36.9M +6.12M +19.9% Jul 27, 2018 10-Q 2018-08-03
Q1 2018 36.8M +6.51M +21.5% Apr 27, 2018 10-Q 2018-05-09
Q3 2017 30.9M +2.42M +8.49% Oct 26, 2017 10-Q 2017-11-03
Q2 2017 30.8M +2.33M +8.2% Jul 27, 2017 10-Q 2017-08-04
Q1 2017 30.3M +1.84M +6.47% Apr 27, 2017 10-Q 2017-05-09
Q3 2016 28.5M +453K +1.61% Oct 26, 2016 10-Q 2016-11-04
Q2 2016 28.5M +4.53M +18.9% Jul 29, 2016 10-Q 2016-08-05
Q1 2016 28.4M +4.5M +18.8% Feb 26, 2016 10-K 2016-03-04
Q3 2015 28.1M +4.34M +18.3% Nov 9, 2015 10-Q 2015-11-10
Q2 2015 24M +457K +1.95% Jul 29, 2015 10-Q 2015-08-07
Q1 2015 23.9M +5.23M +28% Feb 28, 2015 10-K 2015-03-04
Q3 2014 23.7M Nov 5, 2014 10-Q 2014-11-13
Q2 2014 23.5M Aug 1, 2014 10-Q 2014-08-13
Q1 2014 18.7M May 13, 2014 10-Q 2014-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.